About: Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community
Creator	Aysenne, Aimee Beighley, Adam Bui, Cuong Carr, ; Carr, Christopher Dumont, Aaron Keen, Joseph Kilgore, Mitchell Mathkour, Mansour Maulucci, Christopher Scullen, ; Scullen, Tyler Werner, Cassidy Zeoli, Tyler Zweifler, Richard
source	Elsevier; Medline; PMC; WHO
abstract	Abstract Background The coronavirus disease of 2019 (COVID-19) that is caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently been designated a pandemic by the World Health Organization, affecting 2.7 million individuals globally as of April 25, 2020 with over 187,000 deaths. A growing body of evidence supports central nervous system (CNS) involvement. Methods We conducted a review of the literature for articles concerning COVID-19 pathophysiology, neurological manifestations, and neuroscience provider recommendations and guidelines. Results CNS manifestations range from vague non-focal complaints to severe neurologic impairment associated with encephalitis. It is unclear whether neurological dysfunction is due to direct viral injury or systemic disease. The virus may affect brainstem pathways that lead to indirect respiratory dysfunction in addition to direct pulmonary injury. Necessary adaptations in patient management, triage, and diagnosis are evolving in light of ongoing scientific and clinical findings. Conclusions This review consolidates the current body of literature regarding the neurological impact of coronaviruses, discusses the reported neurologic manifestations of COVID-19, and highlights recommendations for patient management. Specific recommendations pertaining to clinical practice for neurologists and neurosurgeons are provided.
has issue date	2020-05-06(xsd:dateTime)
bibo:doi	10.1016/j.wneu.2020.04.222
bibo:pmid	32387786
has license	els-covid
sha1sum (hex)	821ac6fe434122ec2c5d6c85449b5bf32e97e44f
schema:url	https://doi.org/10.1016/j.wneu.2020.04.222
resource representing a document's title	Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community
has PubMed Central identifier	PMC7202815
has PubMed identifier	32387786
schema:publication	World Neurosurg
resource representing a document's body	covid:821ac6fe434122ec2c5d6c85449b5bf32e97e44f#body_text
is schema:about of	named entity 'disease' named entity 'coronavirus' named entity 'individuals' named entity 'Coronavirus' named entity 'COVID-19' named entity 'DESIGNATED' named entity 'CENTRAL NERVOUS SYSTEM' named entity 'OF EVIDENCE' named entity 'globally' named entity 'evidence' named entity 'central nervous system (CNS)' named entity '2019' named entity 'World Health Organization' named entity 'SARS-CoV-2' named entity 'COVID' named entity 'Neurological' named entity 'Impact of Coronavirus' named entity 'Neuroscience' named entity 'SARS-CoV-2' named entity 'seizures' named entity 'lung' named entity 'COVID' named entity 'health status' named entity 'infection' named entity 'AIS' named entity 'Antibodies' named entity 'ACE inhibitors' named entity 'neurotropism' named entity 'Telemedicine' named entity 'neurosurgery' named entity 'viral encephalitis' named entity 'pediatric neurosurgery' named entity 'neurological symptoms' named entity 'supportive care' named entity 'PCR' named entity 'powered air-purifying respirator' named entity 'PAPR' named entity 'intubation' named entity 'HIV' named entity 'pleural effusion' named entity 'respiratory illness' named entity 'RT-PCR' named entity 'influenza' named entity 'pathology' named entity 'surgical intervention' named entity 'neurological symptoms' named entity 'coronaviruses' named entity 'viremia' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'acute respiratory distress syndrome' named entity 'COVID' named entity 'IgG antibody' named entity 'cerebral hemorrhages' named entity 'coronavirus' named entity 'CMV' named entity 'follow-up' named entity 'virus' named entity 'insomnia' named entity 'SARS-CoV-2' named entity 'neuroscience' named entity 'COVID' named entity 'neurological disease' named entity 'seizure' named entity 'systematic review' named entity 'necrotizing' named entity 'RT-PCR'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software